Table S3. from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models

Hirokazu Suzuki; Shotaro Nagase; C. Saito; Atsuko Takatsuka; Motoko Nagata; Kokichi Honda; Yuki Kaneda; Yumi Nishiya; Tomoyo Honda; Tomomichi Ishizaka; Kensuke Nakamura; Takashi Nakada; Yuki Abe; Toshinori Agatsuma

doi:10.1158/1535-7163.25338007.v1

Table S3. from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models

Hirokazu Suzuki, Shotaro Nagase, C. Saito, Atsuko Takatsuka, Motoko Nagata, Kokichi Honda, Yuki Kaneda, Yumi Nishiya, Tomoyo Honda, Tomomichi Ishizaka, Kensuke Nakamura, Takashi Nakada, Yuki Abe, Toshinori Agatsuma

In: American Association for Cancer Research · 2024 · doi:10.1158/1535-7163.25338007.v1 · W4392384147

preprint OA: gold CC0

📄 Open PDF View on OpenAlex View at publisher

Abstract

Concentration of sCDH6 in cell culture supernatant.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK